摘要: Disclosed herein are compounds useful as modulators of TGR5 and methods for the treatment or prevention metabolic, cardiovascular, inflammatory diseases.
David George GlaxoSmithKline Allen, Diane Mary GlaxoSmithKline Coe, Caroline Mary GlaxoSmithKline Cook, Michael Dennis GlaxoSmithKline Dowle, Christopher David Edlin, Julie Nicole GlaxoSmithKline Hamblin, Martin Redpath Johnson, Paul Spencer GlaxoSmithKline Jones, Mika Kristian Lindvall, Charlotte Jane GlaxoSmithKline Mitchell, Alison Judith Redgrave, Naimisha GlaxoSmithKline Trivedi, None, Pyrazolo ’3,4-b! pyridine compounds, and their use as phosphodiesterase type 4 (pde4) inhibitors ,(2005)
Jonathan Mark Argenta Discovery Limited Sutton, Mark Richard Ashton, David Edward Argenta Discovery Limited Clark, Robert Alexander Pharmagene Lab. Ltd. Coleman, Kenneth Lyle Pharmagene Lab. Ltd. Clark, Shirley Ann Brunton, Keith A. J. Argenta Discovery Limited Stuttle, Garry Argenta Discovery Limited Fenton, Neil Victor Argenta Discovery Limited Harris, George Argenta Discovery Hynd, Richard Jon Pharmagene Lab. Ltd. Davis, Edward Andrew Boyd, Alexander William Pharmagene Lab. Ltd. Oxford, Ep2- receptor agonists ,(2005)